SEC Form 4 · accession 0001225208-16-037551
PFIZER INC · PFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian C Read
Officer — Chairman & CEO · Director
Period of report
Aug 3, 2016
Accepted (ET)
Aug 5, 2016 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000078003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2016 | I | 954,993 | $35.29 | D | 252,093 | D | |
| Common Stock | holding | — | — | — | 10,383 | I | By Rule 16b-3 Plan | |
| Common Stock | holding | — | — | — | 480,000 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person transferred shares held in the Pfizer Inc Deferred Compensation Plan ("DCP") into an alternative investment under the DCP in accordance with the DCP's investment alternatives pursuant to the Diversification and Sales Plan entered into on June 2, 2016 between the reporting person and the issuer, which plan was intended to comply with SEC Rule 10b5-1.